植物組織培養市場－全球產業規模、佔有率、趨勢、機會、預測：按成分、植物類型、應用、地區和競爭格局分類，2021-2031年

全球植物組織培養市場預計將從 2025 年的 4.1162 億美元成長到 2031 年的 6.0878 億美元，複合年成長率為 6.74%。

這項技術是在無菌條件下，在營養培養基上培養植物細胞，從而獲得基因相同的克隆體。它是生產高品質、無病原體且不受季節限制的種植材料的關鍵步驟。對高產作物和優質觀賞植物日益成長的需求正在推動該行業的發展，因為它有助於維持商業農業的繁榮。正如國際園藝種植者協會所指出的，預計到2024年，全球觀賞園藝產業規模將達到700億美元，凸顯了對繁殖材料的巨大需求，而這正是組織培養市場的基礎。

進一步擴張的驅動力在於對新品種植物的快速繁殖的需求，而這些新品種無法透過傳統的繁殖方法實現，尤其是在林業和園藝領域。儘管實驗室的自動化程度正在逐步提高，但與精細的手動操作相關的、需要專門基礎設施的高昂營運成本仍然是市場成長的主要障礙。因此，成長的主要障礙是熟練技術人員的嚴重短缺，這推高了生產成本，並限制了在價格敏感型市場中的擴充性。

市場促進因素

政府加強對農業生物技術研究的投入和支持，正從根本上改變全球植物組織培養市場，為技術創新和基礎建設提供必要的資金。公共部門的投資日益集中於基因研究和合成生物學領域，這些領域高度依賴組織培養流程進行繁殖和再生。這些資金支持使實驗室能夠升級無菌設施並實施先進的自動化技術，從而直接降低該行業的高昂營運成本。例如，英國研究與發展組織（UKRI）於2025年11月宣布，英國政府已將其在生物技術領域的投資增加近三倍，達到6.44億英鎊，以促進成長和創新。這些措施將降低商業機構的財務風險，並為大規模微繁殖技術的發展創造有利環境。

同時，對高產、無病害種苗日益成長的需求成為關鍵的商業性驅動力，領先的農產品企業正致力於利用組織培養技術大規模克隆優良基因。由於病原體威脅傳統的作物繁殖方式，組織培養提供的無菌環境確保了健康、潔淨的初始種苗供應，這對糧食安全至關重要。各公司正投入大量資金研發這些抗病品種。根據拜耳公司2025年3月發布的《2024年度報告》，該公司作物科學部門已在研發方面投資26億歐元，凸顯了農業產業對創新的堅定承諾。這種高品質種苗的需求支撐著整個供應鏈，而先正達集團2025年第一季73億美元的銷售額也印證了基於組織培養技術的先進農產品在全球範圍內的巨大規模。

市場挑戰

熟練技術人員的嚴重短缺是全球植物組織培養市場成長的主要障礙。由於組織培養過程仍然是勞力密集的，需要精細的手工操作和專業的技能來維持擴充性和遺傳一致性，因此技術人員短缺直接增加了營運成本並限制了規模化生產。與可以輕鬆過渡到全面自動化的行業不同，植物組織培養在精確的切取和繼代培養作業方面仍然高度依賴人工經驗。因此，如果實驗室無法聘用足夠訓練有素的技術人員，就會出現生產瓶頸，可能無法滿足全球對高品質種植材料日益成長的需求。

勞動力短缺正導致巨大的經濟損失和市場機會的喪失。高職缺率迫使生產者限制產量，有效地抑制了依賴植物品種快速繁殖的園藝景觀產業的擴張。例如，加拿大園藝景觀協會在2024年報告稱，由於勞動力短缺，園藝景觀產業將遭受5億美元的銷售損失。這些數據凸顯了勞動力不足如何直接導致利潤下降，並阻礙市場的整體成長。

市場趨勢

大麻和工業大麻專用組織培養通訊協定的快速發展正在重塑市場格局。這主要源自於對無病害、基因均一克隆植株的需求。微繁殖技術能夠大規模生產具有精確複製的品種特徵的植株，滿足商業種植的需求，其均一性遠超傳統種子繁殖。該領域正經歷爆炸性成長，而先進的無菌操作流程對於解決優質種苗供不應求至關重要。根據美國農業部2025年4月發布的《國家大麻報告》，2024年美國大麻總產量將達4.45億美元，比前一年增加40%。這直接推動了工業規模微繁殖技術的普及應用。

同時，組織培養技術正發展成為基於CRISPR基因編輯工作流程中的基礎再生平台。各實驗室正在引進精準的基因組編輯工具，以培育具有改良性狀的獨特品種，這些品種需要利用體外技術從單細胞再生為單株植物。領先的農業生物技術公司正大力投資於此應用領域，旨在為下一代作物獲取智慧財產權。正如Corteva AgriScience在2025年4月發布的《2024年影響力報告》中所強調的，該公司正在加大對基因編輯平台的投資，每天投入約400萬美元用於研發和創新，凸顯了支撐這些先進再生技術的雄厚資金實力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球植物組織培養市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依組成部分（培養基、試劑、設備/容器）
  • 植物種類（一年生植物、二年生植物、多年生植物）
  • 按應用領域（農業、林業/植物園、園藝/裝飾、調查、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美植物組織培養市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲植物組織培養市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區植物組織培養市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲植物組織培養市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲植物組織培育市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球植物組織培養市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• HiMedia Laboratories Pvt. Ltd
• 3R Biotech
• Merck KGaA
• Labland Biotech Private Limited
• Melford Laboratories Ltd.
• RUBI LABORATORIES, INC.
• Phytoclone Inc
• PhytoTech Labs, Inc.
• Caisson Labs Inc.
• Thomas Scientific LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Plant Tissue Culture Market is projected to expand from USD 411.62 Million in 2025 to USD 608.78 Million by 2031, registering a CAGR of 6.74%. This technique relies on the sterile in vitro cultivation of plant cells on nutrient media to create genetically identical clones, a critical process for producing high-quality planting materials that are free from pathogens and not bound by seasonal limitations. The industry is driven by increasing requirements for high-yield crops and premium ornamental plants to sustain commercial agriculture. As noted by the International Association of Horticultural Producers, the global ornamental horticulture sector was valued at $70 billion in 2024, emphasizing the substantial demand for propagation materials that underpins the tissue culture market.

Further expansion is fueled by the need for rapid multiplication of novel plant varieties, especially within forestry and floriculture, which conventional propagation cannot achieve. Although laboratories are progressively integrating automation, the market faces a substantial hurdle regarding high operational expenses due to the delicate, manual nature of the process requiring specialized infrastructure. Consequently, a primary challenge hindering growth is the severe scarcity of skilled technical staff, which increases production costs and limits scalability in price-sensitive markets.

Market Driver

Escalating government funding and support for agricultural biotechnology research is fundamentally transforming the Global Plant Tissue Culture Market by supplying essential capital for technical innovation and infrastructure. Public sector investments are increasingly focused on genetic research and engineering biology, fields that depend heavily on tissue culture workflows for propagation and regeneration. This financial support allows laboratories to modernize sterile facilities and implement advanced automation, directly mitigating the sector's high operational expenses. For instance, UK Research and Innovation announced in November 2025 that the UK government had nearly tripled its investment in engineering biology to £644 million to stimulate growth and innovation. Such initiatives decrease financial risks for commercial entities and create an environment favorable for large-scale micropropagation developments.

Simultaneously, the growing necessity for high-yielding and disease-free planting material serves as a crucial commercial catalyst, pushing major agribusinesses toward tissue culture for the mass cloning of superior genetics. With pathogens posing threats to traditional crop propagation, the sterile environment provided by tissue culture guarantees the supply of vigorous, clean starting material necessary for food security. Corporations are allocating vast resources to develop these resilient varieties; according to Bayer's "Annual Report 2024" released in March 2025, its Crop Science division invested €2.6 billion in research and development, highlighting the industry's dedication to agricultural innovation. This demand for premium inputs supports the entire supply chain, as evidenced by Syngenta Group reporting first-quarter sales of $7.3 billion in 2025, demonstrating the immense global scale for advanced agricultural products underpinned by tissue culture.

Market Challenge

The severe shortage of skilled technical personnel represents a critical impediment to the growth of the Global Plant Tissue Culture Market. This deficit directly increases operational costs and constrains scalability because the tissue culture process remains labor-intensive, requiring delicate manual steps and specialized handling to maintain sterility and genetic uniformity. Unlike industries that can easily shift to complete automation, plant tissue culture continues to depend heavily on human expertise for precise excision and sub-culturing tasks. As a result, when laboratories are unable to recruit sufficient trained technicians, they encounter production bottlenecks that hinder their ability to satisfy the rising global demand for high-quality planting materials.

This workforce gap leads to substantial economic losses and missed market opportunities. High vacancy rates compel producers to restrict their output, effectively stalling expansion in a sector that depends on the rapid multiplication of plant varieties. For example, the Canadian Nursery Landscape Association reported in 2024 that the floriculture and nursery landscape industry suffered $500 million in lost sales specifically due to job vacancies. This data highlights how the inability to adequately staff operations results directly in diminished revenue and inhibits the overall trajectory of the market.

Market Trends

The rapid development of specialized tissue culture protocols for cannabis and industrial hemp is reshaping the market, fueled by the essential requirement for disease-free, genetically uniform clones. Micropropagation facilitates the mass production of true-to-type plants necessary for commercial cultivation, offering a level of consistency that traditional seed propagation cannot provide. This segment is undergoing explosive growth, requiring advanced sterile workflows to address the supply shortage of premium planting material. According to the USDA's "National Hemp Report" from April 2025, the total value of U.S. hemp production reached $445 million in 2024, a 40 percent increase from the prior year, which is directly accelerating the adoption of industrial-scale micropropagation.

Concurrently, tissue culture is evolving into a fundamental regeneration platform for CRISPR-based gene editing workflows. Laboratories are incorporating precise genome editing tools to create proprietary plant varieties with improved traits, which must be regenerated from single cells into whole plants using in vitro techniques. This application draws significant capital from major ag-biotech companies seeking to secure intellectual property in next-generation crops. As noted in Corteva Agriscience's "Impact Report 2024" published in April 2025, the company has increased its investment in gene editing platforms and commits nearly $4 million daily to R&D innovation, underscoring the massive financial backing supporting these advanced regeneration technologies.

Key Market Players

• HiMedia Laboratories Pvt. Ltd
• 3R Biotech
• Merck KGaA
• Labland Biotech Private Limited
• Melford Laboratories Ltd.
• RUBI LABORATORIES, INC.
• Phytoclone Inc
• PhytoTech Labs, Inc.
• Caisson Labs Inc.
• Thomas Scientific LLC

Report Scope

In this report, the Global Plant Tissue Culture Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Plant Tissue Culture Market, By Component

• Media
• Reagents
• Equipment & Containers

Plant Tissue Culture Market, By Plant Type

• Annual Plants
• Biennial Plants
• Perennial Plants

Plant Tissue Culture Market, By End Use

• Agriculture
• Forestry and Botanical Garden
• Gardening & Decoration
• Research
• Others

Plant Tissue Culture Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Plant Tissue Culture Market.

Available Customizations:

Global Plant Tissue Culture Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plant Tissue Culture Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Media, Reagents, Equipment & Containers)
  • 5.2.2. By Plant Type (Annual Plants, Biennial Plants, Perennial Plants)
  • 5.2.3. By End Use (Agriculture, Forestry and Botanical Garden, Gardening & Decoration, Research, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Plant Tissue Culture Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Plant Type
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Plant Tissue Culture Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Plant Type
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Plant Tissue Culture Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Plant Type
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Plant Tissue Culture Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Plant Type
      • 6.3.3.2.3. By End Use

7. Europe Plant Tissue Culture Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Plant Type
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Plant Tissue Culture Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Plant Type
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Plant Tissue Culture Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Plant Type
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Plant Tissue Culture Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Plant Type
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Plant Tissue Culture Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Plant Type
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Plant Tissue Culture Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Plant Type
      • 7.3.5.2.3. By End Use

8. Asia Pacific Plant Tissue Culture Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Plant Type
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Plant Tissue Culture Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Plant Type
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Plant Tissue Culture Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Plant Type
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Plant Tissue Culture Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Plant Type
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Plant Tissue Culture Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Plant Type
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Plant Tissue Culture Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Plant Type
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Plant Tissue Culture Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Plant Type
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Plant Tissue Culture Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Plant Type
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Plant Tissue Culture Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Plant Type
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Plant Tissue Culture Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Plant Type
      • 9.3.3.2.3. By End Use

10. South America Plant Tissue Culture Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Plant Type
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Plant Tissue Culture Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Plant Type
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Plant Tissue Culture Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Plant Type
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Plant Tissue Culture Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Plant Type
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Plant Tissue Culture Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. HiMedia Laboratories Pvt. Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. 3R Biotech
• 15.3. Merck KGaA
• 15.4. Labland Biotech Private Limited
• 15.5. Melford Laboratories Ltd.
• 15.6. RUBI LABORATORIES, INC.
• 15.7. Phytoclone Inc
• 15.8. PhytoTech Labs, Inc.
• 15.9. Caisson Labs Inc.
• 15.10. Thomas Scientific LLC

16. Strategic Recommendations

17. About Us & Disclaimer